| scholarly article | Q13442814 |
| P50 | author | Jean-Emmanuel Bibault | Q43379650 |
| P2093 | author name string | Ingeborg Tinhofer | |
| P2860 | cites work | A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study | Q39087110 |
| A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity | Q39200585 | ||
| Prediction of radiation sensitivity using a gene expression classifier | Q40384787 | ||
| Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation. | Q40784146 | ||
| Exomics and immunogenics: Bridging mutational load and immune checkpoints efficacy | Q41983246 | ||
| A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. | Q42208433 | ||
| Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients | Q43681440 | ||
| Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer | Q49885799 | ||
| Limits to Personalized Cancer Medicine | Q53768091 | ||
| Perspective: The precision-oncology illusion | Q57765633 | ||
| Gain of oncogenic function of p53 mutants induces invasive phenotypes in human breast cancer cells by silencing CCN5/WISP-2 | Q81469203 | ||
| Genetics and genomics of radiotherapy toxicity: towards prediction | Q21183971 | ||
| Mapping and quantifying mammalian transcriptomes by RNA-Seq | Q22122035 | ||
| A Mutant-p53/Smad complex opposes p63 to empower TGFbeta-induced metastasis | Q24312492 | ||
| EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy | Q27824812 | ||
| Prognostic significance of truncating TP53 mutations in head and neck squamous cell carcinoma | Q27851637 | ||
| TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence. | Q27851687 | ||
| Sequencing technologies - the next generation | Q27860568 | ||
| Comprehensive genomic characterization of head and neck squamous cell carcinomas | Q28256121 | ||
| Genome-wide mapping of in vivo protein-DNA interactions | Q29547162 | ||
| A framework for variation discovery and genotyping using next-generation DNA sequencing data | Q29547262 | ||
| Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1 | Q29614651 | ||
| The mutational landscape of head and neck squamous cell carcinoma | Q29614654 | ||
| A rapid method for determining sequences in DNA by primed synthesis with DNA polymerase | Q29615980 | ||
| TP53 mutations and survival in squamous-cell carcinoma of the head and neck. | Q30366618 | ||
| An Overview of the Analysis of Next Generation Sequencing Data | Q34087270 | ||
| A decade's perspective on DNA sequencing technology | Q34163657 | ||
| Independent validation of genes and polymorphisms reported to be associated with radiation toxicity: a prospective analysis study | Q34240634 | ||
| Circulating tumor DNA as a non-invasive substitute to metastasis biopsy for tumor genotyping and personalized medicine in a prospective trial across all tumor types | Q34457638 | ||
| A gene expression model of intrinsic tumor radiosensitivity: prediction of response and prognosis after chemoradiation | Q34572724 | ||
| Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas | Q35008028 | ||
| Next-generation sequencing of RNA and DNA isolated from paired fresh-frozen and formalin-fixed paraffin-embedded samples of human cancer and normal tissue | Q35176679 | ||
| Differences Between Colon Cancer Primaries and Metastases Using a Molecular Assay for Tumor Radiation Sensitivity Suggest Implications for Potential Oligometastatic SBRT Patient Selection | Q35782954 | ||
| Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing. | Q35892011 | ||
| Feasibility of Large-Scale Genomic Testing to Facilitate Enrollment Onto Genomically Matched Clinical Trials | Q35998823 | ||
| The radiosensitivity index predicts for overall survival in glioblastoma | Q36544110 | ||
| New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology | Q37160539 | ||
| Directed evolution of ionizing radiation resistance in Escherichia coli | Q37301986 | ||
| Genomic analysis of exceptional responders to radiotherapy reveals somatic mutations in ATM. | Q37705828 | ||
| Next-generation sequencing and epigenomics research: a hammer in search of nails. | Q37709045 | ||
| Validation of a radiosensitivity molecular signature in breast cancer. | Q37714313 | ||
| Personalized radiation therapy and biomarker-driven treatment strategies: a systematic review | Q38099763 | ||
| Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation | Q38378172 | ||
| Emerging molecular networks common in ionizing radiation, immune and inflammatory responses by employing bioinformatics approaches | Q38405769 | ||
| Tumour genomic and microenvironmental heterogeneity for integrated prediction of 5-year biochemical recurrence of prostate cancer: a retrospective cohort study | Q38431287 | ||
| P304 | page(s) | 16-20 | |
| P577 | publication date | 2017-04-09 | |
| P1433 | published in | Clinical and Translational Radiation Oncology | Q50817416 |
| P1476 | title | The role of Next-Generation Sequencing in tumoral radiosensitivity prediction | |
| P478 | volume | 3 |
Search more.